Page last updated: 2024-09-04

glycylphenylalanine 2-naphthylamide and Glioma

glycylphenylalanine 2-naphthylamide has been researched along with Glioma in 1 studies

*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y; Zhou, Y; Zhu, K1

Other Studies

1 other study(ies) available for glycylphenylalanine 2-naphthylamide and Glioma

ArticleYear
Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Antineoplastic Agents; Astrocytes; Cathepsin D; Cell Line, Tumor; Cell Movement; Dipeptides; Exocytosis; Gene Knockdown Techniques; Glioma; Heterocyclic Compounds, 4 or More Rings; Humans; Lysosomal Membrane Proteins; Lysosomes; Neoplasm Invasiveness; Pepstatins; Protein Transport; rab GTP-Binding Proteins; rab27 GTP-Binding Proteins; RNA Interference

2012